Levobunolol compared with timolol: a four-year study.
AUTOR(ES)
Geyer, O
RESUMO
Fifty-one patients with raised intraocular pressure (IOP) were treated for up to four years with one of three ophthalmic solutions: 0.5% levobunolol, 1% levobunolol, or 0.5% timolol. The study was conducted as a double-masked, randomised trial in which medications were administered twice daily to both eyes. Levobunolol and timolol were equally effective in reducing overall mean IOP; reductions were greater than 8.8 mmHg in all three treatment groups. The study showed levobunolol to be as safe and effective as timolol in the long-term control of raised IOP.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1041616Documentos Relacionados
- Four-year mortality by some socioeconomic indicators: the Oslo study.
- Epidemiology of Pseudomonas aeruginosa in a general hospital: a four-year study.
- Susceptibility of urinary pathogens to various antimicrobial substances: a four-year study.
- A four-year experience with splenectomy versus splenorrhaphy.
- A four-year experience with splenectomy versus splenorrhaphy.
